Try our Advanced Search for more refined results

Expert Analysis

Patent Use Codes In The Wake Of Caraco V. Novo Nordisk

Law360, New York (May 17, 2012, 1:15 PM EDT) -- The U.S. Supreme Court, in a unanimous decision in Caraco Pharmaceutical Laboratories Ltd. v. Novo Nordisk A/S, No. 10-844 (U.S. April 17, 2012), held that generic drug companies may counterclaim to challenge "use code" listings asserted against them by branded drug manufacturers. The court reversed the Federal Circuit's ruling that generic drug companies had no litigation-based means to challenge incorrect or overbroad use code listings....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!